Objective: This study aimed at exploring the effect of preoperative risk factors and hospital characteristics on costs of coronary artery bypass graft (CABG) hospitalizations.
T he number of coronary artery bypass graft (CABG) surgeries in the United States approached half a million per year in 2005. 1 The considerable number of CABG procedures performed combined with the fact that the procedure constitutes a revenue generator have encouraged hospitals to invest in the establishment of cardiac surgery programs. [2] [3] [4] [5] However, the considerable investment by hospitals in such programs-which will have/had an impact on public and private health care spending-was not coupled with comparable efforts to explore the associated determinants of costs. Most of the studies that examined costs of CABG procedures were focused on the effect of demographic characteristics, 6 -12 the comparison among clinical techniques to perform the procedure (eg, off-pump vs. conventional CABG), [13] [14] [15] [16] [17] and the differences in costs among the various coronary revascularization procedures (eg, percutaneous coronary angioplasty vs. stenting; CABG vs. PCI; thrombolytic treatment vs. PCI. etc). 18 -27 Few investigations examined the effect of patient clinical risk factors and hospital characteristics on CABG costs.
The aim of this study was to explore the effect of clinical risk factors and hospital characteristics on costs of CABG hospitalization. Such an investigation is merited as the health care delivery system is going into a new phase where the concept of value-based purchasing, in which providers are compared not only based on quality but also efficiency, is a key component. Hospitals that are able to demonstrate favorable efficiency in health care delivery will be rewarded. As such, identifying-and controlling for-the factors that affect performance on efficiency measures, in this case costs, will allow for optimal comparative evaluation.
METHODS

Study Population
The study population was comprised of New York State residents who underwent an isolated CABG procedure in the state during 2003. The cases-total number of cases was 12,016 -were derived from hospitals that were certified by the State to perform the procedure in 2003 (33 hospitals).
Data Sources
Data for the study was derived from: ( Data elements derived from the Medicare Cost Report and wage index files included department-level costs, intern and resident to bed ratios and market wage indices, as well as facility identifiers for data linkage. The Medicare Cost Report was linked to the AHA dataset to extract hospital characteristics (ownership, size, teaching status, and operating margin) using the facility identifier. It is worth noting that a one-item survey was conducted with the 33 hospitals in the study to examine whether they use clinical pathways for CABG patients. The study was approved by the State University of New York at Albany Institutional Review Board.
Study Variables
The study outcome measure was costs of CABG discharges. These were derived by applying the ratios of costs to charges for the index claim. This method had shown a correlation of Ͼ0.90 with internal accounting costs in previous studies. 28, 29 The total costs for each of the claims were standardized based on the hospital that the case was treated in. The costs were standardized based on 1 indirect medical education costs and 2 labor wage index. The Balanced Budget Act of 1997 and subsequent legislation reduced the IME adjustment overtime from 7.7% percent for every 10 percentage point increment in the ratio of residents to hospital beds to 5.5% percent for every 10 percentage point. 30 However, a Medicare Payment Advisory Commission analysis showed that "Inpatient Operating costs increased about 2.7% for every 10% increment in the resident-to-bed ratio." We used this MedPAC analysis with IME to appropriately adjust the costs of teaching hospitals in this study. The PPS statute requires that Secretary of Health and Human Services must adjust the standard PPS payment rate for area differences in hospital wages. Currently, the labor share, as determined by the Centers for Medicare and Medicaid Services, (CMS) is 71.066%. Recent legislation requires that the labor share be set at 62% for hospitals with a wage index of less than 1.0000. 31 In our adjustment of hospital costs, we applied the wage index adjustment only to the empirically determined labor share of 71.066% to adjust a hospital's costs for its wage index.
Independent variables included patient and hospital characteristics. Patient characteristics included age, gender, and preprocedural risk factors (eg, ejection fraction, number of diseased vessels, previous AMI, comorbidities, etc). The use of similar patient characteristics has been employed by others in establishing reimbursement models or examining the utility of clinical risk factors as predictors of hospital charges and costs. [32] [33] [34] [35] Hospital characteristics comprised ownership, teaching status, size, operating margin, volume, and use of clinical pathways. The latter was included because of the potential effect of clinical pathways on cost of cardiac procedures. 36 -40 
Data Analysis
The bivariate association between each of the independent measures and costs was examined through the use of t-tests and analysis of variance. Multivariate analysis was conducted using a 2-level hierarchical model to examine the effect of patient and hospital characteristics on hospital costs for CABG (patients nested in hospitals). A 2-level hierarchical model was fit to predict log normalized costs. Observations with outlier costs (Ͼ$55,000)-246 (2%) were excluded. The level-1 model incorporated patient-level characteristics. The level-2 model investigated the influence of hospital-level factors. First, a stepwise multivariable regression was fit using patient demographics and risk factors to predict log cost. All variables significant at the 0.05 level were then included as level-1 factors and modeled as random effects. The level-1 intercept was modeled as random with hospital factors as fixed effect predictors. Age, gender, race, and clinical risk factors (as individual variables) were level-1 predictors, and ownership, teaching, size, CABG volume, and use of clinical pathways are level-2 predictors.
RESULTS
There were a total of 12,016 patients and 33 hospitals in the study. Table 1 presents the prevalence of patient and hospital characteristics included in the study, as well as the bivariate association between each of these characteristics and costs. More than half of patients (55.8%) were 65 years of age with most patients (72.3%) being men. Approximately nine-tenths of patients (81.8%) were white; a majority of patients (57.5%) had an ejection fraction of 50% or more. Most patients (52.9%) did not have a previous myocardial infarction with a small percentage (4.2%) of patients had undergone a previous open heart surgery. The most common comorbidity was diabetes (34.7%). More than half of patients (52.1%) had 3 diseased vessels. More than four-fifths of hospitals (84.8%)
were not-for-profit. The number of teaching hospitals was almost double that of nonteaching hospitals with discharge costs increased by hospital size (P Ͻ 0.001). Most hospitals had an operating margin that was between 0% and 4.99%; approximately, one-third of hospitals (30.3%) had performed 500 or more CABG procedures during the study period with more than half of the hospitals (51.5%) employing clinical pathways for CABG. Table 2 presents the results of the multivariate hierarchical linear model of CABG discharge costs. It is worth noting that the effect of patient and hospital characteristics was presented as exponentiated parameter estimates of the model coefficients. The number of years beyond age 65 was associated with higher costs (P Ͻ 0.001). Being a female was associated with 5% more cost compared with males (P Ͻ 0.001); so was being black which was associated with 4% more costs compared with other races (P Ͻ 0.05). The ejection fraction was also significantly associated with costs; lower fraction rates were associated with higher costs. Several comorbidities were found to increase CABG discharge costs; these included carotid/cerebrovascular disease, femoral/popliteal disease, the occurrence of congestive heart failure in the index admission, malignant ventricular arrhythmia, chronic obstructive pulmonary disease, and renal failure. In addition, the presence of left main disease was associated with 5% higher costs (P Ͻ 0.001), so was having 3 diseased vessels (P Ͻ 0.001). Having undergone a previous open heart surgery was found to be associated with 10% higher costs (P Ͻ 0.001).
At the second level of the hierarchical structure, larger hospitals were associated with increased costs. Compared with hospitals with less than 440 beds, CABG discharge costs at hospitals with 440 to 749 were 29% higher (P Ͻ 0.001), and at hospitals with 750 or more beds even higher by 41% (P Ͻ 0.001). Conversely, a higher number of CABG procedures performed at the index hospitals was associated with lower CABG discharge costs. Hospitals that performed 250 to 499 CABG procedures during the study year had 15% lower costs (P Ͻ 0.05) than those with less than 100 procedures performed (reference group). Furthermore, hospitals that had a total CABG volume that was 500 or more procedures were found to be associated with costs that were 19% lower than the reference group (P Ͻ 0.05).
DISCUSSION
The level of health expenditures on CABG procedures and the financial success of new cardiac programs have led to an increased interest in better understanding the cost determinants of the procedure. 28,29,36 -43 However, few studies explored the effect of patient and hospital characteristics on CABG costs. Ferraris et al assessed the association between patient risk factors and hospital costs. 41 The study concluded that certain clinical risk factors such as preoperative congestive heart failure and serum creatinine levels among others were associated with increased CABG costs. However, the study only investigated patient risk factors and did not explore the associated potential effect of hospital characteristics on costs. Other investigations focused more on hospital-based costs; a study exploring the variability in hospital-based costs of CABG reported considerable variations in costs among hospitals, even after controlling for patient clinical risk factors. 42 Similarly, Cowper et al 43 detected considerable variability in hospital costs of CABG among states. However, although these studies examined patient and hospital characteristics, the aim was not to explore their effect on CABG costs. This study was aimed at investigating patient and hospital determinants of CABG discharge costs in an effort to identify significant cost drivers as a first step to potentially better design/enhance cost reducing strategies.
Saleh et al
Annals Findings revealed that selected demographic characteristics, including older age, female gender and being black, were associated with higher costs. Furthermore, several clinical characteristics were found to affect CABG discharge costs such as lower ejection fraction, the duration between CABG admission and the occurrence of myocardial infarction, number of diseased vessels, previous open heart operations, and a number of comorbidities. The findings of the effect of demographic and clinical characteristics on CABG discharge costs are consistent with that of other investigations that examined preoperative determinants of CABG costs. 6,44 -47 Understanding the differential impact of these risk factors, specifically clinical, can aid in cost containment efforts, eg, possibility of intervention among patients with certain preoperative characteristics for cost reduction techniques. 41, 48, 49 In addition, given the expected exclusion of complications as basis for DRG assignment/upgrading 50 and the CMS decision to use costs to determine DRG weights in 2008, it will be important to properly code comorbid patient risk factors, especially those associated with higher costs.
Another set of factors examined included hospital characteristics. The findings revealed that larger hospitals had higher CABG discharge costs. On the other hand, costs significantly decreased with increased CABG volume. Perhaps the former finding is more challenging to interpret given the different factors that may cause such a relationship, eg, inefficiencies of larger hospitals or the fact that larger hospitals are more likely to be teaching hospitals and these usually have higher costs than nonteaching hospitals. A more relevant finding is the association between high procedure volume and lower costs; such an association has been widely documented for a number of procedures. [51] [52] [53] Very few studies explored the association between volume and discharge costs for coronary revascularization procedures and these reported similar results. 54 As such, it can be argued that to enhance efficiency, providers should aim to attract more CABG procedures to their facility-specifically 250 or more procedures per year based on study findings. Furthermore, payers may reward, eg, selectively contract, with high-volume-and consequently lower costs-hospitals as part of implementing a valuebased purchasing system. 55 There are several limitations in the study that merit consideration. First, generalization may be limited by the fact that the study used data derived from one state. Second, the study was based on data derived from procedures that occurred in 2003. Changes in surgical practices in the past 5 years may have a potential effect on cost structures and determinants. Third, it is possible that hospital characteristics, other than those examined in the study, eg, staffing, operating room scheduling, also affect CABG discharge costs. However, given the nature of the datasets used, it was not possible to extract such information. Finally, the study used clinical risk factors which are not collected in most states or in national dataset (eg, MedPAR). Hence, the replicability of the results may be limited-especially since most current administrative data do not differentiate between comorbidities and complications. Fortunately, CMS will revise the severity adjustments of DRGs to reflect differences that would help make that differentiation by 2008. 56 In conclusion, several patient and hospital characteristics affect CABG discharge costs. Hospitals should explore ways to reduce the impact of such characteristics, when possible, in an attempt to reduce costs.
